CVS HEALTH CORPORATION Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
CVS HEALTH CORPORATION (CVS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $785.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-10
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $621.00M.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $335.00M.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $312.00M.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-03-31 was $556.00M.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $785.00M, a 7.86% decline from fiscal 2024.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $852.00M, a 24.73% decline from fiscal 2023.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.13B, a 91.54% increase from fiscal 2022.
- CVS HEALTH CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $591.00M, a 52.87% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $785.00M 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $852.00M 10-K · filed 2026-02-10 | |||
| 2023-12-31 | $1.13B 10-K · filed 2026-02-10 | |||
| 2022-12-31 | $591.00M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $1.25B 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $1.68B 8-K · filed 2023-05-25 | |||
| 2019-12-31 | $621.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $956.00M derived: sum of 2 quarters · filed 2022-02-09 | $1.27B derived: sum of 3 quarters · filed 2022-02-09 | $1.82B 10-K · filed 2022-02-09 |
| 2019-09-30 | $335.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $647.00M derived: sum of 2 quarters · filed 2019-11-06 | $1.20B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $312.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $868.00M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $556.00M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |